Tag: ROADSTER
TCAR: First patient enrolled in ROADSTER 3 post-approval study
Silk Road Medical has announced enrollment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicenter, single-arm...
Silk Road to evaluate TCAR in standard surgical risk patients with...
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularization (TCAR) system in the treatment of standard surgical risk patients...
‘TCAR yields high technical success with an extraordinarily low stroke and...
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularization (TCAR) treatment for carotid stenosis in the ROADSTER...
Study: The ‘successful’ operation of TCAR in a community practice setting
A research team in Dallas demonstrated the successful operation of transcarotid artery revascularization (TCAR) in a community practice setting, reporting results in line with...